RA
Actavia Life Sciences, Inc.
RASP · OTC
$0.00 +0.00% (+$0.00)
Market Cap $385.9K
P/E Ratio -
Div. Yield -
ROE -
Piotroski F-Score Weak
1/9Valuation
-
N/A PEG N/A
P/E N/A
P/B N/A
Growth
-
N/A FCF growth N/A
EPS growth N/A
Book val. growth N/A
Profitability
-
N/A Op. margin N/A
Gross margin N/A
FCF margin N/A
Quality
57 /100
Average Asset turnover 0.00x
ROIC 242.88%
ROA 4,644.72%
Debt
0 /100
High Int. coverage -19.86x
Current ratio 0.05x
Debt/Assets N/A
Stability
32 /100
Unstable Profitable years 0
Beta -6.96x
EPS volatility 55.32%
Bulios Scoring opisuje jakość i historię firmy, a nie przyszły zwrot. Wysoki wynik to nie sygnał zakupu. Dowiedz się więcej
Zapytaj StockBota o RASP
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Keeren Shah
Employees
1
Headquarters
New York City